According to the latest report by IMARC Group, titled “Carrier Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global carrier screening market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/carrier-screening-market/requestsample
Carrier screening represents a genetic testing technique that aids in identifying abnormal genes in fetuses that can cause autosomal recessive diseases. This is a predictive and pre-symptomatic testing solution used by couples and pregnant individuals to analyze the risks of the child inheriting genetic disorders, such as sickle cell anemia, cystic fibrosis, Tay-Sachs disease, etc., from their parents. It requires testing a sample of saliva, blood, or cheek tissue, using different molecular and biochemical processes based on deoxyribonucleic acid (DNA) sequencing, microarray technologies, polymerase chain reaction (PCR), etc. Carrier screening is utilized for expanded, customized panels, predesigned panels, and targeted disease carrier screening for numerous hematological, pulmonary, and neurological disorders.
The rising prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is among the primary factors driving the carrier screening market. Moreover, the growing awareness among individuals about the benefits of early detection and diagnosis of diseases is further catalyzing the market growth. Besides this, molecular screening tests are also gaining traction for identifying DNA mutations in the genetic codes and for detecting mutations that can cause pre-leukemia, heart defects, Down syndrome, etc. Additionally, carrier screening helps in providing adequate prenatal and reproductive care and facilitating proper management of heritable diseases, which is also propelling the product demand. In the coming years, the development of next-generation sequencing (NGS) techniques is expected to fuel the carrier screening market.
Carrier Screening Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global carrier screening market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Fulgent Genetics
- Gene By Gene Ltd. (MyDNA)
- Illumina Inc.
- Invitae Corporation
- MedGenome Labs Ltd.
- Myriad Genetics Inc.
- Natera Inc.
- OPKO Health Inc.
- Quest Diagnostics
- Sema4
- Thermo Fisher Scientific Inc.
Key Market Segmentation:
The report has segmented the global carrier screening market on the basis of type, medical condition, technology, end user and region.
Breakup by Type:
- Expanded Carrier Screening
- Targeted Disease Carrier Screening
Breakup by Medical Condition:
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Others
Breakup by Technology:
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Others
Breakup by End User:
- Hospitals and Clinics
- Reference Laboratories
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/carrier-screening-market
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
The legal age to purchase and use marijuana in Canada is 19 Buy cheap weed online in canada years of age.
In recent years, the ability to buy weed online has become increasingly popular, especially in places where cannabis is legal. Buying weed online offers several benefits, including convenience, privacy, and a wider selection of products.
One of the main benefits of using an buy weed online canada is the convenience it offers. Customers can browse products, place orders, and have them delivered to their doorstep, all from the comfort of their own homes. This is especially useful for those who live in remote areas, or who have mobility issues and find it difficult to travel to a physical dispensary.
Definitely what a great blog and instructive posts I definitely will bookmark your site.All the Best!